Research has also shown that insulin resistance, in combination with Metabolic Associated Steatotic Liver Disease (MASLD), contributes to increased expression of PAI-1 and several adhesion molecules, which leads to the progression of atherosclerotic lesions, proliferation of VSMC, and the subsequent development of restenosis [16,31,42,53]. This evidence concerns the gene SERPINE1 and Insulin resistance.